Ocular microbiota and lens contamination following Mel4 peptide-coated antimicrobial contact lens (MACL) extended wear.


Journal

Contact lens & anterior eye : the journal of the British Contact Lens Association
ISSN: 1476-5411
Titre abrégé: Cont Lens Anterior Eye
Pays: England
ID NLM: 9712714

Informations de publication

Date de publication:
02 2022
Historique:
received: 28 08 2020
revised: 31 01 2021
accepted: 20 02 2021
pubmed: 8 3 2021
medline: 27 1 2022
entrez: 7 3 2021
Statut: ppublish

Résumé

The purpose of this study was to investigate the effect of Mel4 antimicrobial peptide-coated contact lenses (MACL) on the microbiota of the conjunctiva and lenses during three months of extended wear. One hundred and seventy-six participants were recruited into a randomised, contralateral, double masked, biweekly extended wear MACL and uncoated control lens trial. At the one month and 3-month visit, the conjunctival microbiota was sampled using sterile cotton swabs and contact lenses were collected aseptically. Standard microbiological procedures were employed for culture of the swabs and contact lenses and identification of the isolated microorganisms. Gram-positive bacteria (predominantly coagulase-negative staphylococci) were the most frequently isolated microbes from both contact lenses and conjunctiva. There was no difference in the frequency of isolation of most bacteria or fungi from the conjunctival swabs of eyes wearing either MACL or control lenses. The only exception was a higher frequency of eyes harbouring Staphylococcus arlettae when wearing control lenses (5%) versus MACL (<1%) (p = 0.002). There was no significant difference in the frequency of microbes isolated from MACL or control contact lenses. There were also no differences between lens types in the frequency of isolation of >1 microbial type per sampling occasion for either conjunctiva swabs or contact lenses. MACL wear did not change the conjunctival microbiota during extended wear, and the types of microbes isolated from MACL were similar to those isolated from control lenses.

Identifiants

pubmed: 33676840
pii: S1367-0484(21)00031-X
doi: 10.1016/j.clae.2021.02.017
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antimicrobial Peptides 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101431

Informations de copyright

Copyright © 2021 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

Parthasarathi Kalaiselvan (P)

School of Optometry and Vision Science, UNSW Sydney, Australia. Electronic address: p.kalaiselvan@unsw.edu.au.

Debarun Dutta (D)

School of Optometry and Vision Science, UNSW Sydney, Australia; Optometry and Vision Science Research Group, Aston University, Birmingham, United Kingdom.

Faiza Bhombal (F)

Bausch & Lomb Contact Lens Centre, L V Prasad Eye Institute, Hyderabad, India.

Nagaraju Konda (N)

School of Medical Sciences, University of Hyderabad, Hyderabad, India.

Pravin Krishna Vaddavalli (PK)

Bausch & Lomb Contact Lens Centre, L V Prasad Eye Institute, Hyderabad, India; The Cornea Institute, L V Prasad Eye Institute, Hyderabad, India.

Savitri Sharma (S)

Jhaveri Microbiology Centre, L V Prasad Eye Institute, Hyderabad, India.

Fiona Stapleton (F)

School of Optometry and Vision Science, UNSW Sydney, Australia.

Mark D P Willcox (MDP)

School of Optometry and Vision Science, UNSW Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH